Non-AIDS-defining malignancies and HAART
Laurence, J.
Aids Reader 17(9): 433-434
2007
ISSN/ISBN: 1053-0894 PMID: 17902222 Document Number: 608308
Document emailed within 1 workday
Related Documents
Manfredi, R.; Calza, L. 2009: Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy Recenti Progressi in Medicina 100(12): 547-549Tanaka, L.F.; Latorre, M.d.R.ár.D.; Gutierrez, E.B.; Heumann, C.; Herbinger, K.-H.; Froeschl, G. 2017: Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil International Journal of Std and Aids 28(12): 1190-1198
Wen, Y.; Shi, Y.; Jiang, C.; Detels, R.; Wu, D. 2013: HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China Aids Care 25(7): 915-925
Laurence, J. 2003: Impact of HAART on HIV-linked malignancies Aids Reader 13(5): 202; 205
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Tancredi, M.V.; Waldman, E.A. 2014: Predictors of progression to AIDS after HIV infection diagnosis in the pre- and post-HAART eras in a Brazilian AIDS-free cohort Transactions of the Royal Society of Tropical Medicine and Hygiene 108(7): 408-414
Grinsztejn, B.; Luz, P.M.; Pacheco, A.G.; Santos, D.V.G.; Velasque, L.; Moreira, R.I.; Guimarães, M.Regina.C.; Nunes, Eão.P.; Lemos, A.S.; Ribeiro, S.R.; Campos, D.P.; Vitoria, M.A.A.; Veloso, V.G. 2013: Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era Plos one 8(4): E59768
Mosthaf, F.A.; Goetzenich, A.; Ostrop-Hanhoff, N.J.; Wolf, E.; Knechten, H.; Von Wussow, P. 2016: Incidence of AIDS- and non-AIDS-defining malignomas in HIV-positive patients-A nation-wide German overview 2000-2002 Journal of Clinical Oncology 24(18_Suppl): 7554-7554
Abaasa,A.M.; Todd,J.; Ekoru,K.; Kalyango,J.N.; Levin,J.; Odeke,E.; Karamagi,C.A.S. 2008: Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme the experience of The AIDS Support Organization , Kampala, Uganda Bmc Health Services Research: 241, (20 Ember)
Abaasa,A.M.; Todd,J.; Ekoru,K.; Kalyango,J.N.; Levin,J.; Odeke,E.; Karamagi,C.A.S. 2008: Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme the experience of The AIDS Support Organization , Kampala, Uganda Bmc Health Services Research: 241, (20 Ember)
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Carter, A.J.; Bourgeois, S.; O'Brien, N.; Abelsohn, K.; Tharao, W.; Greene, S.; Margolese, S.; Kaida, A.; Sanchez, M.; Palmer, A.K.; Cescon, A.; de Pokomandy, A.; Loutfy, M.R.; Loutfy, M.R.; de Pokomandy, A.; Kaida, A.; Hogg, B.; Margolese, S.; Abelsohn, K.; Carter, A.J.; Fraser, S.; O'Brien, N.; Bakombo, D.; Brisebois, C.L.; Dayle, J.; Inoua, H.; Kwaramba, G.; Larkin, K.; Ménard, B.; Nicholson, V.; Rawson, S.; Smith, S.; Abelsohn, K.; Anema, A.; Bakombo, D.; Brisebois, C.L.; Carter, A.J.; Cescon, A.; Dayle, J.; de Pokomandy, A.; Hogg, B.; Greene, S.; Inoua, H.; Kaida, A.; Fraser, S.; Kwaramba, G.; Larkin, K.; Lewis, J.; Loutfy, M.R.; Margolese, S.; Ménard, B.; Nicholson, V.; O'Brien, N.; Palmer, A.; Rawson, S.; Smith, S.; Tharao, W.; Bur 2013: Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS Journal of the International Aids Society 16: 17433
Saksena, N.K.; Smit, T.K. 2005: HAART and the molecular biology of AIDS dementia complex Indian Journal of Medical Research 121(4): 256-269
Castilla, J.; Gutiérrez, A.; Noguer, I. 1996: Changes in the spectrum of AIDS-defining diseases in Spain Medicina Clinica 106(19): 730-733
Morgan, D.; Malamba, S.S.; Orem, J.; Mayanja, B.; Okongo, M.; Whitworth, J.A. 2000: Survival by AIDS defining condition in rural Uganda Sexually Transmitted Infections 76(3): 193-197
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Akanmu, A.S. 2006: AIDS-associated malignancies African Journal of Medicine and Medical Sciences 35 Suppl: 57-70
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Sabin, C.A.; Pasi, K.J.; Phillips, A.N.; Lilley, P.; Bofill, M.; Lee, C.A. 1996: Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A BMJ 312(7025): 207-210
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452